Annual Accounts Payable
$607.00 K
-$234.00 K-27.82%
March 31, 2024
Summary
- As of February 7, 2025, SNOA annual accounts payable is $607.00 thousand, with the most recent change of -$234.00 thousand (-27.82%) on March 31, 2024.
- During the last 3 years, SNOA annual accounts payable has fallen by -$1.16 million (-65.69%).
- SNOA annual accounts payable is now -79.61% below its all-time high of $2.98 million, reached on March 31, 2008.
Performance
SNOA Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$1.40 M
+$625.00 K+81.17%
December 31, 2024
Summary
- As of February 7, 2025, SNOA quarterly accounts payable is $1.40 million, with the most recent change of +$625.00 thousand (+81.17%) on December 31, 2024.
- Over the past year, SNOA quarterly accounts payable has increased by +$531.00 thousand (+61.46%).
- SNOA quarterly accounts payable is now -66.25% below its all-time high of $4.13 million, reached on June 30, 2020.
Performance
SNOA Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
SNOA Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -27.8% | +61.5% |
| 3 y3 years | -65.7% | +65.9% |
| 5 y5 years | -51.6% | +65.9% |
SNOA Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -65.7% | at low | -32.2% | +129.8% |
| 5 y | 5-year | -70.6% | at low | -66.3% | +129.8% |
| alltime | all time | -79.6% | at low | -66.3% | +176.8% |
Sonoma Pharmaceuticals Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | - | $1.40 M(+81.2%) |
| Sep 2024 | - | $770.00 K(+2.5%) |
| Jun 2024 | - | $751.00 K(+23.7%) |
| Mar 2024 | $607.00 K(-27.8%) | $607.00 K(-29.7%) |
| Dec 2023 | - | $864.00 K(-12.5%) |
| Sep 2023 | - | $987.00 K(-9.4%) |
| Jun 2023 | - | $1.09 M(+29.6%) |
| Mar 2023 | $841.00 K(-48.8%) | $841.00 K(-35.4%) |
| Dec 2022 | - | $1.30 M(+21.2%) |
| Sep 2022 | - | $1.07 M(-47.8%) |
| Jun 2022 | - | $2.06 M(+25.4%) |
| Mar 2022 | $1.64 M(-7.2%) | $1.64 M(+3.7%) |
| Dec 2021 | - | $1.58 M(-15.6%) |
| Sep 2021 | - | $1.88 M(+2.5%) |
| Jun 2021 | - | $1.83 M(+3.5%) |
| Mar 2021 | $1.77 M(-14.4%) | $1.77 M(-27.2%) |
| Dec 2020 | - | $2.43 M(-24.1%) |
| Sep 2020 | - | $3.20 M(-22.5%) |
| Jun 2020 | - | $4.13 M(+100.0%) |
| Mar 2020 | $2.07 M(+64.7%) | $2.07 M(-4.3%) |
| Dec 2019 | - | $2.16 M(-5.8%) |
| Sep 2019 | - | $2.29 M(+51.0%) |
| Jun 2019 | - | $1.52 M(+21.0%) |
| Mar 2019 | $1.25 M(-1.3%) | $1.25 M(+14.0%) |
| Dec 2018 | - | $1.10 M(-19.2%) |
| Sep 2018 | - | $1.36 M(+1.9%) |
| Jun 2018 | - | $1.34 M(+5.0%) |
| Mar 2018 | $1.27 M(+1.4%) | $1.27 M(-9.1%) |
| Dec 2017 | - | $1.40 M(+9.8%) |
| Sep 2017 | - | $1.27 M(+64.7%) |
| Jun 2017 | - | $774.00 K(-38.3%) |
| Mar 2017 | $1.25 M(-6.1%) | $1.25 M(+14.9%) |
| Dec 2016 | - | $1.09 M(-15.0%) |
| Sep 2016 | - | $1.28 M(-6.1%) |
| Jun 2016 | - | $1.37 M(+2.3%) |
| Mar 2016 | $1.34 M | $1.34 M(-8.7%) |
| Dec 2015 | - | $1.46 M(+26.1%) |
| Sep 2015 | - | $1.16 M(-3.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2015 | - | $1.20 M(+29.0%) |
| Mar 2015 | $932.00 K(+26.6%) | $932.00 K(-1.1%) |
| Dec 2014 | - | $942.00 K(-10.4%) |
| Sep 2014 | - | $1.05 M(+11.5%) |
| Jun 2014 | - | $943.00 K(+28.1%) |
| Mar 2014 | $736.00 K(-8.9%) | $736.00 K(-55.1%) |
| Dec 2013 | - | $1.64 M(+59.5%) |
| Sep 2013 | - | $1.03 M(+0.2%) |
| Jun 2013 | - | $1.02 M(+26.9%) |
| Mar 2013 | $808.00 K(-1.0%) | $808.00 K(+60.3%) |
| Dec 2012 | - | $504.00 K(-35.6%) |
| Sep 2012 | - | $783.00 K(+13.2%) |
| Jun 2012 | - | $692.00 K(-15.2%) |
| Mar 2012 | $816.00 K(+22.0%) | $816.00 K(-7.2%) |
| Dec 2011 | - | $879.00 K(+45.3%) |
| Sep 2011 | - | $605.00 K(-22.6%) |
| Jun 2011 | - | $782.00 K(+16.9%) |
| Mar 2011 | $669.00 K(-31.8%) | $669.00 K(-14.9%) |
| Dec 2010 | - | $786.00 K(-19.5%) |
| Sep 2010 | - | $976.00 K(+18.2%) |
| Jun 2010 | - | $826.00 K(-15.8%) |
| Mar 2010 | $981.00 K(-37.3%) | $981.00 K(+10.8%) |
| Dec 2009 | - | $885.00 K(-21.6%) |
| Sep 2009 | - | $1.13 M(-14.4%) |
| Jun 2009 | - | $1.32 M(-15.7%) |
| Mar 2009 | $1.56 M(-47.4%) | $1.56 M(-4.2%) |
| Dec 2008 | - | $1.63 M(+26.8%) |
| Sep 2008 | - | $1.29 M(-28.1%) |
| Jun 2008 | - | $1.79 M(-39.8%) |
| Mar 2008 | $2.98 M(+16.7%) | $2.98 M(+96.5%) |
| Dec 2007 | - | $1.51 M(+5.9%) |
| Sep 2007 | - | $1.43 M(-21.2%) |
| Jun 2007 | - | $1.81 M(-28.9%) |
| Mar 2007 | $2.55 M(-8.0%) | $2.55 M(+27.4%) |
| Dec 2006 | - | $2.00 M(-12.4%) |
| Sep 2006 | - | $2.29 M(-17.6%) |
| Mar 2006 | $2.77 M(+206.2%) | $2.77 M(+206.2%) |
| Mar 2005 | $906.00 K | $906.00 K |
FAQ
- What is Sonoma Pharmaceuticals annual accounts payable?
- What is the all time high annual accounts payable for Sonoma Pharmaceuticals?
- What is Sonoma Pharmaceuticals annual accounts payable year-on-year change?
- What is Sonoma Pharmaceuticals quarterly accounts payable?
- What is the all time high quarterly accounts payable for Sonoma Pharmaceuticals?
- What is Sonoma Pharmaceuticals quarterly accounts payable year-on-year change?
What is Sonoma Pharmaceuticals annual accounts payable?
The current annual accounts payable of SNOA is $607.00 K
What is the all time high annual accounts payable for Sonoma Pharmaceuticals?
Sonoma Pharmaceuticals all-time high annual accounts payable is $2.98 M
What is Sonoma Pharmaceuticals annual accounts payable year-on-year change?
Over the past year, SNOA annual accounts payable has changed by -$234.00 K (-27.82%)
What is Sonoma Pharmaceuticals quarterly accounts payable?
The current quarterly accounts payable of SNOA is $1.40 M
What is the all time high quarterly accounts payable for Sonoma Pharmaceuticals?
Sonoma Pharmaceuticals all-time high quarterly accounts payable is $4.13 M
What is Sonoma Pharmaceuticals quarterly accounts payable year-on-year change?
Over the past year, SNOA quarterly accounts payable has changed by +$531.00 K (+61.46%)